Amphix Bio, Inc.

Funding and NIH signals

• SEC Form D raise Raised $10.3M (Form D filed Dec 19, 2025). SEC Form D 0002101704-25-000001 (Dec 19, 2025)
  Evidence (1 event)

  • Dec 19, 2025 · SEC Form D 0002101704-25-000001
    Name of Issuer: Amphix Bio, Inc.; CIK: 2101704; Address: Chicago, IL; Submission type: D; Filing date: 2025-12-19; Industry Group: Biotechnology; Date of First Sale: 2025-12-04; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 12500000; Total Amount Sold: 10300000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals